Tracing Polymer Nanoparticle Peptide Delivery Ownership From Academic Filing to Spinout License
How universities, tech transfer offices.
Daniel Ngô
Section
Nanomedicine Platforms
10 stories in Nanomedicine Platforms.
Transneuronal and Transcellular Transport Mechanisms That Nanoparticle Formulations Must Exploit for Peptide CNS Delivery via the Nasal Route
Marcus Oyelaran
Academic Peptide Nanoparticle Patent Portfolios Evaluated by Platform Architecture Not Publication Volume
Platform architecture, not publication count, reveals whether a nanoparticle system can scale.
Priya Subramaniam
Nose-to-Brain Nanoparticle Platform Differentiation Across Reward Circuit and Dementia Indications
Nanoparticle design must match delivery to brain circuit, not just cross the barrier.
Marcus Oyelaran
Intranasal Nanoparticle Platform Developers Advancing Peptide CNS Indications From Discovery to Clinic
Nanoparticles deliver peptides across the blood-brain barrier through the nose.
Priya Subramaniam
Benchmarking University Spinout IP Estates Across Nanoparticle Peptide Delivery Platforms
Patent count alone cannot predict whether a university nanoparticle platform is defensible.
Daniel Ngô
Intellectual Property Landscape of Nanoparticle Drug Delivery Patents
COVID-19 vaccines sparked a patent race that reshaped nanoparticle drug delivery.
Priya Subramaniam
Nanoparticle Platforms Engineering Peptide Blood-Brain Barrier Crossing
Nanoparticles hijack the brain barrier's own transport systems to deliver peptide drugs.
Cecilia Brandt-Kowalski
Nanoparticle Scale-Up Challenges From Lab Bench to GMP Manufacturing
Particle properties shift unpredictably when equipment scales up.
Marcus Oyelaran
Lipid Nanoparticles vs Polymeric Nanoparticles for Delivering Peptides to the CNS
Lipid nanoparticles excel at endosomal escape; polymeric ones protect peptides better in transit.
Marcus Oyelaran